Infra, family office and continuation funds will play a bigger role in healthcare service M&A in 2021, with a strong pipeline of assets in a 'bumpy market', Rothschild's managing director of healthcare M&A Hedley Goldberg told delegates at HBI 2020.
Sell-side advisors Perella Weinberg are reportedly circulating teasers for in-administration international operator NMC Health's core GCC business with a view to a potential sale in April. We look at the potential for the potential new owners to consolidate the UAE hospital market.
Middle-market M&A is picking up again across healthcare sub-sectors in Europe, but investors are still reluctant to take the leap on larger assets. We round up where deals are - and aren't happening, and why. There is close to €1.2bn revenue up for grabs in the dentistry sector, nearly €1bn in the psychiatry sector, and around €750m in other outpatient services like ophthalmology and IVF.
People over the age of 80 are up to three times more likely to die of a COVID-19 infection in countries using rigid rationing guidelines that can exclude the elderly from intensive care - and sometimes even from hospital. HBI's extensive analysis of death, hospital and ICU data reveals that Sweden has lost eight times more, England seven and the Netherlands six of its elderly population compared to Germany. In a special report, we explore how rationing killed the elderly.
Global renal care group Diaverum's upcoming Stockholm IPO has 'strong international and Swedish investor interest', CEO Dimitris Moulavasilis tells HBI, as the market reaches historic highs. We talk expansion and diversification plans and 2020 performance.
Pfizer shares rocketed 15% on Monday with news of a vaccine that's more than 90% effective. But lab and telehealth shares plummeted upon the announcement while hospitals, care homes and outpatient groups recouped some of their YTD losses. HBI explores what a vaccine might mean across the five sub-sectors.
Netherlands-based medicalised homecare provider and pharmaceutical distributor Mediq is for sale, with a potential €1.2bn price tag. With non-binding bids for the pan-European group due in the first week of November, HBI hears that a private equity buyer is almost certain with little interest from strategic parties.
UK-based NHS dental specialist IDH, which operates over 600 UK-based clinics as {my}dentist and supplies thousands of dentists with products and equipment through dental supplier DD, is for sale. Could the group could be broken up if the buyer for the whole is not found?
HBI speaks exclusively to George Spanos, chairman and CEO of Greece's largest primary care and diagnostic chain, about the company's plans for the future and whether rumours the company might be for sale are true.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.